🔬 Celebrating a breakthrough from Dr. Raju Tomer's lab @Columbia, just published in @NatureBiotech!
SCOPE technology SLICE microscopy = affordable, high-resolution 3D imaging for all.
Dr. Tomer's team developed SCOPE, which transforms inexpensive air objectives into submicron-resolution tools. Combined with SLICE (which we commercialized from his pLSM invention), researchers can image centimeter-scale samples at nanoscale detail.
The research team—spanning Columbia, NIH, Lehigh, NYU Langone, and MBF—demonstrated:
• Whole mouse & salamander brains
• Human tissue 3D histopathology
• Brain organoids with microglia
• Multi-immersion compatibility
This collaboration shows what's possible when academic innovation meets commercial accessibility. Dr. Tomer invented the platform; we help make it available to labs worldwide.
Huge congratulations to Dr. Tomer, the biologist collaborators, and the entire research team! This is the kind of science that expands what's possible for everyone. 🎉
Read the full paper: nature.com/articles/s41587-0…#Microscopy#Neuroscience#LightSheet#ScientificImaging#Innovation#SLICElightsheetmicroscope
A deep convolutional neural network model predicts the influence of the full-length mRNA sequence on translation efficiency go.nature.com/4mgXR0Crdcu.be/flWMe
Biotech’s coming of age
Biotech is back. But continued investor caution, the rise of China and fast-moving AI are changing the sector’s contours nature.com/articles/s41587-0…
A decade on, while the basic principles discussed in the first review of the patent landscape of antibody–drug conjugates still apply, the ADC landscape has dramatically evolved and diversified go.nature.com/3RKQ691rdcu.be/fl6wN
New approaches to antivenoms for snakebite lean on cutting-edge techniques, but can they successfully be brought to market? nature.com/articles/s41587-0…
[🔓read free with login]